INO vs MRNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 24, 2026
INO
MRNA
Investment Advisor Scores
MRNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | INO | MRNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 16.5837 | 23.0415 | INO |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -100.0% | 260.2% | MRNA |
| Earnings Growth | 0.0% | -85.1% | INO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.5/100 | 51.6/100 | MRNA |
| Profit Margin | 0.0% | -143.6% | INO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
INO
MarkdownPrice below a falling SMA50 (slope -6.7%), weak momentum, RSI 25
MRNA
NeutralMixed signals - no dominant trend phase, RSI 41
Fundamentals Snapshot
| Metric | INO | MRNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.2 | -11.1 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -1.0% | 0.0% |
| Gross Margin | — | -0.7% |
| Operating Margin | 0.0% | -5.6% |
| EPS | -1.58 | -7.98 |
| Dividend Yield | — | — |